Form 4: Humana Director Marcy S. Klevorn Reports Stock Unit Acquisition

Director Marcy S. Klevorn reports acquisition of Humana stock units through director's fees and dividend reinvestment.

Summary

• Marcy S. Klevorn, a director at Humana Inc., filed a Form 4 detailing changes in beneficial ownership.
• On December 31, 2024, she acquired 17 restricted stock units through dividend reinvestment at a price of $254.93 per unit.
• On January 2, 2025, she acquired 783 restricted stock units as part of her annual director's fee.
• These stock units are deferred until her resignation as a director, at which point they will be payable in Humana Inc. common stock on a 1-for-1 basis.
• Following these transactions, Klevorn directly owns 2,005 derivative securities (restricted stock units) and 436 shares of Humana common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard director compensation practices and reinvestment in the company.

Positives

• The acquisition of stock units demonstrates the director's continued investment in the company's future.
• Dividend reinvestment indicates confidence in the company's performance.

Future Outlook

The stock units will be payable in Humana Inc. common stock on a 1-for-1 basis upon the director's resignation.

Industry Context

Directors often receive stock-based compensation to align their interests with those of shareholders, which is a common practice in the healthcare industry.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders as they are part of standard director compensation.

Key Dates